Navigation Links
Dendreon Reports First Quarter 2008 Financial Results
Date:5/8/2008

gh the discovery, development and commercialization of novel therapeutics to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the efficacy of PROVENGE to treat men suffering from prostate cancer, risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials for PROVENGE will not support approval for a biologics license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a biologics license has been applied, the risk that the results of a clinical trial for PROVENGE or other product may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
2. Dendreon Announces Closing of Registered Direct Offering
3. Dendreon Announces $47 Million Registered Direct Offering
4. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
5. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
6. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
7. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
8. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
9. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
10. Dendreon Reports Third Quarter 2007 Financial Results
11. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... SCOTTSDALE, Ariz., Dec. 2 MedPre...ceutical competitive intelligence and market,rese...l strategic insight for,pharma and biotech compan...sease (PD) therapies. This report, entitled Thoug...isease, is based on 9 interviews conducted with PD...
(Date:12/2/2008)... Managing the transition from perimenopause to po...ewswire/ -- The increasing frequency and intensity...periencing menopause. OBG Management and The Jo...a supplement titled Vasomotor symptoms: Managing ... . In this supplement, James McGregor, MD, CM and ...
(Date:12/2/2008)... TAMPA, Fla., Dec. 2 Associated C...ology group practice that operates seven locations...has selected Sage Intergy EHR,electronic health r...on. The,Cherry Hill, N.J.-based practice, which c... deploy the single-database, integrated solution t...
(Date:12/2/2008)... On Track to File NDA with FDA in Early to Mid-20...wire-FirstCall/ -- Strativa Pharmaceuticals, the p... Companies, Inc. (NYSE: PRX ) today announced th...he successful completion of all pivotal bioequival...etron. The ondansetron thin film product is being ...
Breaking Biology Technology:New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4
...is. - Quick quiz: Which Wisconsin institutions sp...fe sciences? , ,Naming No. 1 is relatively easy: t...) is perennially among the top academic R&D center... Medical College of Wisconsin ($139 million), whi...ch centers. Next up is the University of Wisconsi...
...is. - Scott VanderSanden, who has served as vice ...n since 2001, has been appointed president of AT&...n, who has been with AT&T for 17 years, is credite...ulatory initiatives, including the company,s bid t...e. He also directed the company,s activities in a ...
...is. - The Medical College of Wisconsin has been...study pain relief methods for patients with advanc...e with the services of palliative care consultatio...conditions and activities that lead to better pain...atisfaction with care. , ,The National Cancer Ins...
...ls, Wis. - Cray Inc. , the Seattle-based superco...pment center here, has been awarded a $250 million...d Research Projects Agency to develop what the co...However, the agreement,s impact on Cray,s Chippewa..., which extends Cray,s part in DARPA,s High Produc...
Other Biology Technology:Marshfield Clinic and UW combine to speed tech growth 2Marshfield Clinic and UW combine to speed tech growth 3Marshfield Clinic and UW combine to speed tech growth 4Cray signs $250M deal to develop supercomputer 2
(Date:12/2/2008)...d filter-feeding habits, clams have been silent wi...upon their waters. These clams are silent no more...Sea Lab and her colleagues have reported in their ...iology . Using stable isotope techniques, Carmich...ace wastewater inputs to estuaries and coastal foo...
(Date:12/2/2008)... United States that are at the highest risk of sus...g enough to the dangers posed by rising temperatur...f century of climate change that has already signi...tterns and has already had widespread ecological a...nty that the United States will experience at leas...
(Date:12/2/2008)...an anywhere else in the world. This is having a ma...ban environment and effect of cities on rural area... Africa,s history is being over-looked. , Joy Cl...e problem in the current issue of the African Jou...% of the African population was rural, today 38% l...
(Date:12/2/2008)...rschungsgemeinschaft (DFG, German Research Foundat...ntres. They will be initially funded for the next ...n euros. Among other things, the new Collaborative...es caused by viruses and bacteria, scarring of the...cs include the optimisation of planning, productio...
Breaking Biology News(10 mins):Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 4From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 5From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 6From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 7Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 1Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 2Evolution Physical Therapy First Clinic in Southern California to Introduce NASA Designed Anti Gravity Treadmill for Public Use 28112 3WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 1WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 2WVU study demonstrates efficacy of CT perfusion in diagnosis of acute ischemic stroke 28108 3Santa Monica School Unveils Fresh Fruit 26 Vegetable Snack Program to Combat Obesity 28106 1Santa Monica School Unveils Fresh Fruit 26 Vegetable Snack Program to Combat Obesity 28106 2CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 1CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 2
...mportant counter-balance to the warming of our pla... pollution and other aerosol particles ?appears to...creen" of aerosols since the early 1990s could hav...e temperatures. The finding, published today in th...anding of recent climate change. In a related stud...
... births resulting from in-vitro-fertilization (IVF...ll University have developed a procedure that esti...ryos, possibly leading to a decrease in multiple-i...dergoing IVF. , Over 100,000 in-vitro fertilizatio... States. In 2002, 3.1 embryos on average were tran...
...l bacteria in laboratory experiments and eliminate...g with a key bacterial nutrient, according to rese...The joint project, conducted at the UW, the Univer...ll be featured in the April 2 issue of the Journal...singly resistant to antibiotics, and existing drug...
...flash of light are providing insight into the comp...yield a better understanding of how the human brai...l Center and the Howard Hughes Medical Institute h...ain cells "fire" when exposed to light. This was a...urally present in green algae that "turns on" when...
Other Biology News:Global 'sunscreen' has likely thinned, report NASA scientists 2Global 'sunscreen' has likely thinned, report NASA scientists 3Trojan horse strategy defeats drug-resistant bacteria 2Common algae helps illustrate mammalian brain electrical circuitry 2Common algae helps illustrate mammalian brain electrical circuitry 3
...n is critical to the maintenance of appropriate le...ortant and diverse as those involved in cellular m... presentation, modulation of cell surface receptor...iption, and signalling factors. The ubiquitin-prot...
...r-Activated Receptor-gamma (PPAR) is a member of a...cription factors that heterodimerize with retinoic...egulation of glucose and lipid metabolism. Agonist...called thiazolidinediones (TZD) or "glitazones." R...
... can be used for the identification of potential b... renal and other diseases. Due to the fact that ur...ts, it provides an attractive alternative to blood...s. The ProteoSpin Urine Protein Concentration Mic...
...automated cellular imaging and analysis system is ...d specifically for rapid acquisition and analysis ...sed screening. ImageXpress is fast. Scanning an e...24 pixels), with two fluorescence images per well,...
Biology Products: